Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Landec Corporation
LDECurrent price
5.85 EUR
0 EUR (0.00%)
Last closed
5.6 EUR
Company
www.landec.com
ISIN
US5147661046
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Frankfurt Exchange
Capitalization
208 589 547 EUR
Yield for 12 month
-12.03 %
1Y
3Y
5Y
10Y
15Y
LDE
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota. Address: 3515 Lyman Boulevard, Chaska, MN, United States, 55318
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
13.37 EURP/E ratio
44.1667Dividend Yield
–Current Year
+129 507 541 EUR
Last Year
+104 272 648 EUR
Current Quarter
+24 945 102 EUR
Last Quarter
+38 254 206 EUR
Current Year
+42 256 731 EUR
Last Year
+27 557 245 EUR
Current Quarter
+5 439 355 EUR
Last Quarter
+17 439 863 EUR
Key Figures LDE
1 year
3 years
5 years
10 years
EBITDA
-680 550 EUR
Operating Margin TTM
PE Ratio
44.1667
Return On Assets TTM
-2.25 %
PEG Ratio
3.4052
Return On Equity TTM
17.29 %
Wall Street Target Price
13.37 EUR
Revenue TTM
129 692 319 EUR
Book Value
-0.13 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
0.7 %
Dividend Yield
–
Gross Profit TTM
27 557 245 EUR
Earnings per share
0.12 EUR
Diluted Eps TTM
0.12 EUR
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
5.09 %
Dividend Analytics LDE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History LDE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation LDE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
44.1667
Forward PE
8.7336
Enterprise Value Revenue
2.707
Price Sales TTM
1.6083
Enterprise Value EBITDA
10.2311
Price Book MRQ
13.9591
Financials LDE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LDE
For 52 weeks
3.41 EUR
7.88 EUR
50 Day MA
4.45 EUR
Shares Short Prior Month
–
200 Day MA
5.38 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart